Sale!

APOA5 Gene Hyperchylomicronemia Type 5 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The APOA5 Gene Hyperchylomicronemia Type 5 Genetic Test is a specialized diagnostic procedure designed to detect mutations in the APOA5 gene, which are linked to Type 5 Hyperchylomicronemia, a rare genetic disorder. This condition is characterized by an inability to properly break down fats, leading to a significant increase in the levels of chylomicrons in the blood, which can result in pancreatitis, abdominal pain, and an increased risk of cardiovascular disease. The test is critical for individuals who exhibit symptoms of the disorder or have a family history of hyperlipidemia, as early detection can lead to more effective management and treatment strategies. Conducted at DNA Labs UAE, a leading facility in genetic testing, the cost of the test is 4400 AED. This investment in health allows for a comprehensive understanding of one’s genetic predisposition to this condition, enabling targeted interventions and personalized healthcare planning.

Description

APOA5 Gene Hyperchylomicronemia type 5 Genetic Test

Test Name: APOA5 Gene Hyperchylomicronemia type 5 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Metabolic Disorders

Doctor: General Physician

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for APOA5 Gene Hyperchylomicronemia type 5 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with Hyperchylomicronemia type 5.

Test Details:

APOA5 gene hyperchylomicronemia type 5 NGS genetic test is a diagnostic test used to identify mutations or variations in the APOA5 gene that are associated with hyperchylomicronemia type 5, a rare genetic disorder characterized by extremely high levels of triglycerides in the blood.

Next-generation sequencing (NGS) is a high-throughput DNA sequencing technology that allows for the simultaneous analysis of multiple genes or even the entire genome. In the case of hyperchylomicronemia type 5, NGS can be used to sequence the APOA5 gene and identify any genetic changes or mutations that may be causing the disorder.

The test involves collecting a blood sample from the patient and isolating the DNA. The DNA is then sequenced using NGS technology, and the resulting data is analyzed to identify any variations or mutations in the APOA5 gene. These genetic changes can help confirm a diagnosis of hyperchylomicronemia type 5 and guide appropriate treatment and management strategies.

It is important to note that this test is typically ordered by a healthcare provider or genetic counselor who specializes in genetic disorders. The results of the test should be interpreted by a qualified healthcare professional, as they can provide important information about the patient’s condition and guide appropriate medical interventions.

Test Name	APOA5 Gene Hyperchylomicronemia type 5 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Metabolic Disorders
Doctor	General Physician
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for APOA5 Gene Hyperchylomicronemia type 5 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Hyperchylomicronemia type 5
Test Details	APOA5 gene hyperchylomicronemia type 5 NGS genetic test is a diagnostic test used to identify mutations or variations in the APOA5 gene that are associated with hyperchylomicronemia type 5, a rare genetic disorder characterized by extremely high levels of triglycerides in the blood. Next-generation sequencing (NGS) is a high-throughput DNA sequencing technology that allows for the simultaneous analysis of multiple genes or even the entire genome. In the case of hyperchylomicronemia type 5, NGS can be used to sequence the APOA5 gene and identify any genetic changes or mutations that may be causing the disorder. The test involves collecting a blood sample from the patient and isolating the DNA. The DNA is then sequenced using NGS technology, and the resulting data is analyzed to identify any variations or mutations in the APOA5 gene. These genetic changes can help confirm a diagnosis of hyperchylomicronemia type 5 and guide appropriate treatment and management strategies. It is important to note that this test is typically ordered by a healthcare provider or genetic counselor who specializes in genetic disorders. The results of the test should be interpreted by a qualified healthcare professional, as they can provide important information about the patient’s condition and guide appropriate medical interventions.